FDA Approves RISPERIDONE — Amici Pharma, Inc.

Amici Pharma announced the approval of Risperidone (ANDA077328) on February 24, 2009, positioning the company to capitalize on the expanding market demand for affordable generic antipsychotics. This regulatory milestone signals a significant competitive threat to branded players, aiming to disrupt the landscape by offering a cost-effective therapeutic alternative to the established product.